Related Experiment Video
Updated: May 30, 2026
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
[Surveillance after prostate cancer radiotherapy]
S Supiot1, E Rio, K Clément-Colmou
1Service de radiothérapie, institut de cancérologie de l'Ouest René-Gauducheau, boulevard Jacques-Monod, 44805 Nantes-Saint-Herblain, France. s-supiot@nantes.fnclcc.fr
Summary
Effective follow-up after prostate cancer radiotherapy is crucial for detecting relapse and toxicity. Guidelines recommend clinical, biological, and imaging strategies to ensure patient safety and treatment validation.
Area of Science:
- Oncology
- Radiotherapy
- Urology
Context:
- Prostate cancer radiotherapy requires diligent follow-up to monitor for disease recurrence and treatment side effects.
- Established guidelines from scientific societies outline clinical, biological, and imaging surveillance protocols.
- Emerging evidence supports aggressive salvage therapy for localized recurrence post-radiotherapy.
Purpose:
- To summarize current recommendations for post-prostate cancer radiotherapy follow-up.
- To highlight the importance of detecting local or metastatic relapse and long-term toxicities.
- To underscore the need for validating radiotherapy techniques and dose constraints through patient follow-up.
Summary:
- Follow-up protocols after prostate cancer radiotherapy are essential for early detection of local or metastatic relapse.
- Monitoring for long-term toxicities is critical for managing patient health and adapting treatment strategies.
- Adherence to clinical, biological, and imaging guidelines ensures comprehensive patient care and safety.
Impact:
- Optimized follow-up strategies can lead to timely interventions for recurrent prostate cancer.
- Adequate surveillance aids in the long-term management of treatment-related toxicities.
- Patient follow-up data are vital for refining radiotherapy techniques and ensuring departmental quality assurance.
